HDFC Pharma and Healthcare Fund

HDFC Pharma and Healthcare Fund

Equity

HDFC Mutual Fund

Sector - Healthcare

Get the latest NAV of HDFC Pharma and Healthcare Fund. View historical returns compared to its benchmark and category average. Know which stocks and sectors the fund is investing in. Get an estimate of returns from the SIP and lump sum returns calculator. View detailed holding analysis and peer comparison. Get INDmoney ranking of the fund.

₹17.60

▼-0.6%1D

NAV as on 17 Mar 2026

25.82%/per year

Since Inception

Absolute Gain%

▲▼

12030 people have invested ₹ 2.3Cr in HDFC Pharma and Healthcare Fund in the last three months

HDFC Pharma and Healthcare Fund Performance vs. Nifty 500

Fund returns vs Benchmark returns vs Category Average returns as on (17-Mar-26)

The fund has outperformed the benchmark (Nifty 500) over 1Y, but underperformed over 3Y, 5Y.

Period
1M
3M
6M
1Y
3Y
5Y
This Fund
-1.85%
-0.97%
-2.07%
13.49%
--
--
Nifty 500
-9.13%
-8.96%
-8.76%
5.44%
14.05%
11.67%
Sector - Healthcare Avg
-1.37%
-2.45%
-4.23%
8.73%
24.27%
15.09%
Best in Sector - Healthcare
2.53%
1.06%
-0.2%
14.22%
28.62%
17.76%
Worst in Sector - Healthcare
-2.22%
-6.95%
-7.54%
2.15%
22.17%
12.96%

INDmoney Rank

Powered by IND quant engine

IND ranking is not available for this fund.

Fund Name
INDmoney Rank
AUM (in Crs.)
Expense Ratio
1Y Returns
3Y Returns
3Y Alpha
3Y Beta
3Y Sharpe
3Y Sortino
3Y Info Ratio
HDFC Pharma and Healthcare Fund
-
2,031Cr
0.95%
13.49%
-
--
--
--
--
--
SBI Healthcare Opportunities Fund
1/8
4,077Cr
0.91%
6.21%
25.75%
2.77
0.86
1.35
2.54
0.08
ICICI Prudential Pharma Healthcare and Diagnostics P.H.D Fund
2/8
6,801Cr
1.02%
7.95%
27.95%
2.27
0.94
1.30
2.32
0.44
Mirae Asset Healthcare Fund
3/8
2,844Cr
0.47%
12.19%
26.31%
0.09
0.99
1.17
2.21
-0.06
See all
Positive: Among most bought funds within the category
Among most bought funds within the category
Negative: No bad points found for this fund.
No bad points found for this fund.

HDFC Pharma and Healthcare Fund Returns Calculator

Calculate SIP and lumpsum returns based on historical performance

  • 1-time

  • SIP

Total Investment

0

Profit

Total Corpus

0

Absolute Return
▲
▼

HDFC Pharma and Healthcare Fund Asset Allocation

See fund asset allocation details as on (14-Mar-26)

Fund Distribution

as on (14-Mar-26)

Mid cap
37.3%
Small cap
34.1%
Large cap
26.9%
Mid Cap allocation has gone up from 36.6% to 37.3%
Mid Cap allocation has gone up from 36.6% to 37.3%
Large Cap allocation has gone down from 28.6% to 26.9%
Large Cap allocation has gone down from 28.6% to 26.9%
Small Cap allocation has gone up from 32.2% to 34.1%
Small Cap allocation has gone up from 32.2% to 34.1%
Cash allocation has gone down from 2.7% to 1.8%
Cash allocation has gone down from 2.7% to 1.8%

HDFC Pharma and Healthcare Fund Sector Allocation

See fund sector allocation details as on (14-Mar-26)

Sector Allocation

Health
97.5%
Basic Materials
2.5%

Top 2 Sectors in February were Health, Basic Materials

Feb'26

Health

96%

Basic Materials

4%

Jan'26

Health

96%

Basic Materials

4%

HDFC Pharma and Healthcare Fund Holdings Details

as on (28-Feb-26)

Top Stocks bought last month
Aster DM Healthcare Ltd Ordinary Shares's allocation increased from 3.16% to 5.42%
Aster DM Healthcare Ltd Ordinary Shares's allocation increased from 3.16% to 5.42%
Global Health Ltd's allocation increased from 1.2% to 1.84%
Global Health Ltd's allocation increased from 1.2% to 1.84%
Sai Life Sciences Ltd's allocation increased from 1.64% to 2.09%
Sai Life Sciences Ltd's allocation increased from 1.64% to 2.09%
Top Stocks sold last month
Divi's Laboratories Ltd's allocation decreased from 8.57 % to 8.38 %
Divi's Laboratories Ltd's allocation decreased from 8.57 % to 8.38 %
Glenmark Pharmaceuticals Ltd's allocation decreased from 6.76 % to 6.62 %
Glenmark Pharmaceuticals Ltd's allocation decreased from 6.76 % to 6.62 %
Lupin Ltd's allocation decreased from 6.52 % to 6.44 %
Lupin Ltd's allocation decreased from 6.52 % to 6.44 %

HDFC Pharma and Healthcare Fund Overview

Get key fund statistics, minimum investment details, AUM, expense ratio, exit load, and tax treatment.

Expense ratio0.95%
Benchmark
BSE Healthcare TR INR
AUM₹2031 Cr
Inception Date4 October, 2023
Min Lumpsum/SIP₹100/₹100
Exit Load
1.0%
Lock InNo Lock-in
TurnOver
38.18%
Risk
Risk meter
pointer
Very High Risk

About HDFC Pharma and Healthcare Fund

HDFC Pharma and Healthcare Fund is an equity fund. This fund was started on 4 October, 2023. The fund is managed by Nikhil Mathur, Dhruv Muchhal. The fund could potentially beat inflation in the long-run.

Key Parameters

  1. HDFC Pharma and Healthcare Fund has ₹2031 Cr worth of assets under management (AUM) as on Mar 2026 and is more than category average.
  2. The fund has an expense ratio 1.

Returns

HDFC Pharma and Healthcare Fund has given a CAGR return of 25.82% since inception. Over the last 1 year the fund has given a CAGR return of 13.49%.

Holdings

HDFC Pharma and Healthcare Fund has allocated its funds majorly in Cash Equivalent, Health, Basic Materials. Its top holdings are Sun Pharmaceuticals Industries Ltd, Divi's Laboratories Ltd, Glenmark Pharmaceuticals Ltd, Lupin Ltd, Max Healthcare Institute Ltd Ordinary Shares

Taxation

As it is a sector - healthcare mutual fund the taxation is as follows:
For short term (less than a year) capital gains will be taxed at 20%
For long term (more than 1 year) capital gains will be taxed at 12.5% without indexation benefit
Dividends will always be taxed at slab rate. Long term gains upto Rs 1 lakh are exempt capital gains tax.

Investment objective of HDFC Pharma and Healthcare Fund

To provide long-term capital appreciation by investing predominantly in equity and equity related securities of Pharma and healthcare companies. There is no assurance that the investment objective of the Scheme will be realized.

Minimum Investment and lockin period

Minimum investment for lump sum payment is INR 100.00 and for SIP is INR 100.00. HDFC Pharma and Healthcare Fund has no lock in period.

Fund Manager

Nikhil Mathur

Fund Manager of HDFC Pharma and Healthcare Fund, since 4 October 2023

Dhruv Muchhal

Fund Manager of HDFC Pharma and Healthcare Fund, since 4 October 2023

Learn more about HDFC Mutual Fund
Parameters
Feb'26
Jan'26
Dec'25
AUM
₹ 2K Cr
₹ 1.9K Cr
₹ 2K Cr
  • AUM of the fund stands at 2K Cr as of Feb'26
  • AUM increased by 154.9 Cr between Feb'26 and Jan'26

Frequently Asked Questions for HDFC Pharma and Healthcare Fund

How do I invest in HDFC Pharma and Healthcare Fund?

INDmoney makes it simple to invest in the HDFC Pharma and Healthcare Fund. To do so, follow the steps below:
  • Download the INDmoney app.
  • Search for ‘HDFC Pharma and Healthcare Fund’.
  • Select whether you want to invest in SIP or lump sum.
  • Enter the amount you wish to invest.
  • Set up payments via bank mandate or UPI.

What is the current NAV of HDFC Pharma and Healthcare Fund?

The NAV of the fund today is ₹17.60. NAV or Net Asset Value is the per unit price of a mutual fund. For example, if the NAV of a fund is ₹10, it means you can get 1000 units of that mutual fund at ₹10,000.

What is the return on the fund?

HDFC Pharma and Healthcare Fund fund has generated a return of 13.49% in 1 year

Who is the fund manager of HDFC Pharma and Healthcare Fund?

The fund managers are Nikhil Mathur, Dhruv Muchhal.

What is the exit load of the fund?

The exit load is 1% if redeemed in 0-30 Days. Exit load is a fee levied for ‘exiting’ the fund earlier than a stipulated period, usually 1 year.

What is the expense ratio of the fund?

The expense ratio is 0.95%. The Expense Ratio is a fee charged for managing the fund. This includes commissions, administrative costs etc.

What is the AUM of the fund?

The AUM of the fund is ₹2031 Cr. AUM stands for Assets Under Management. It refers to the total assets managed by the fund.

What are the top holdings of HDFC Pharma and Healthcare Fund?

The top 3 holdings of the fund are Sun Pharmaceuticals Industries Ltd(9.81%), Divi's Laboratories Ltd(8.38%), Glenmark Pharmaceuticals Ltd(6.62%)